Venous Window Access Catheter For Hemodialysis

Information

  • Research Project
  • 7758856
  • ApplicationId
    7758856
  • Core Project Number
    R44CA139608
  • Full Project Number
    4R44CA139608-02
  • Serial Number
    139608
  • FOA Number
    PA-08-050
  • Sub Project Id
  • Project Start Date
    9/25/2008 - 16 years ago
  • Project End Date
    2/28/2010 - 14 years ago
  • Program Officer Name
    EVANS, GREGORY
  • Budget Start Date
    3/1/2009 - 15 years ago
  • Budget End Date
    2/28/2010 - 14 years ago
  • Fiscal Year
    2009
  • Support Year
    2
  • Suffix
  • Award Notice Date
    4/16/2009 - 15 years ago
Organizations

Venous Window Access Catheter For Hemodialysis

DESCRIPTION (provided by applicant): A novel, venous window access device (VWAD), anastomotic tool, and minimally invasive, image-guided surgical procedure to provide hemodialysis for patients suffering from End Stage Renal Disease (ESRD) have undergone early stage development. The device can serve as a destination therapy or as a "bridge device" to provide temporary access during maturation of an arteriovenous (AV) fistula. The device consists of a percutaneous access conduit, anastomosed to a central vein, i.e. the right jugular vein, that serves as an percutaneous access port. Dialysis is performed (three times weekly) by advancing a dual lumen, disposable catheter down the access conduit and into the vein. When not in use, the percutaneous access conduit is back filled with anti-microbial solution and is completely isolated from the circulation by an occluding obturator. The disposable obturator is removed and replaced between dialysis sessions. The technology has several advantages: 1) Anastomosis of the access conduit to the outside of the vein allows the device to reside outside the continuous blood path in the vein, as opposed to conventional, indwelling dialysis catheters. 2) The "outdwelling" configuration of this device will reduce thrombus, stenosis of the healthy vein, and potential for blood communication with the sinus tract. Preliminary in vitro and in vivo studies have identified procedural and design improvements required to reduce this system to clinical practice. The objective of this SBIR fast track proposal is to complete the clinical configuration design, build prototypes, perform in vitro performance and safety testing, and verify in vivo performance with chronic implants in sheep. This project will allow completion of development of a clinical configuration and prepare for Phase II clinical testing and final regulatory submission leading to commercialization of this concept.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R44
  • Administering IC
    CA
  • Application Type
    4
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    1057200
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
    NCI:1057200\
  • Funding Mechanism
    SBIR-STTR
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    VITAL ACCESS, INC.
  • Organization Department
  • Organization DUNS
    180346285
  • Organization City
    SALT LAKE CITY
  • Organization State
    UT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    841202340
  • Organization District
    UNITED STATES